A phase I trial of combination bryostatin 1 and vincristine in HIV-related B-cell neoplasms
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Bryostatin-1; Vincristine
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 25 Jan 2013 Biomarkers information updated
- 25 Oct 2007 Status changed from in progress to completed.
- 04 Oct 2005 New trial record.